Company Data
Puma Biotechnology Inc
Ticker
PBYI
Current Price
$6.96 -2.25%
Market Cap
$354.3M
Price Target
Refer to Report
Volume
174.9K
52wk Range
$3.03 - $7.8983
Overview
Puma Biotechnology Inc is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. The company in-licenses the global development and commercialization rights to PB272 (neratinib, oral), PB272 (neratinib, intravenous) and PB357.